MAXHEAL introduced a third operational unit, viz. MAXHEAL Laboratories Pvt. Ltd., at the Special Economic Zone (SEZ) in Sachin, near Surat. This site is equipped with EU-GMP, WHO-GMP, NAFDAC, FDB (Ghana), and Ethiopia-approved facilities. Its infrastructure is par excellence, compatible with UK-MHRA standards, and a team of equally qualified personnel adds another feather to MAXHEAL’s cap.
The plant is well-connected by rail, road, and air transport and is located approximately 271 km from Mumbai.
| Product | Daily Production Capacity |
| Tablets | 20,00,000 No./Shift |
| Capsules | 10,00,000 No./Shift |
| Dry Syrup | 10,000 Bottels/Shift |
| Svp-Ampules | 1,00,000 No./Shift |
| Svp-Vials-10ml | 40,000 No./Shift |
| Svp-Eyedrops | 20,000 No./Shift |
| Dry powder Inj | 40,000 No./Shift |
| Sachets | 40,000 No./Shift |
| TOTAL SITE AREA | 14,400 Sq Mt. |
| TOTAL CONSTRUCTED AREA | 14,400 Sq Mt. - 2 Storey building |
| QC & QA AREA | 850 Sq Mt |
| AREA AVAILABLE FOR EXPANSION | 5100 Sq Mt. |
| FACILITIES | Tablets, Capsules |
| EMPLOYEE STRENGTH | 225 to 250 |
| FACILITIES PLANNED | Injectables, Oral Rehydration Salt, Dry Powder |
| ANNUAL MANUFACTURING CAPACITY | Tablets 1000 million. Capsules 750 million |
| PROJECTED MANUFACTURING CAPACITY | Tablets 1000 million, Capsules 750 million |
| ACCREDITATION'S | WHO-cGMP, NAFDAC, FDB-Ghana |